Table I.
Control | SHPT | ||||
---|---|---|---|---|---|
Variable | No. of patients | % | No. of patients | % | P-value |
Total (n=498) | 74 | 100 | 424 | 100 | |
Age, years (mean ± SD) | 51.26±15.74 | 49.45±16.33 | 0.476 | ||
Gender | 0.047a | ||||
Male | 53 | 71.62 | 252 | 59.43 | |
Female | 21 | 28.38 | 172 | 40.57 | |
Underlying cause | 0.445 | ||||
Primary glomerular diseases | 41 | 55.41 | 226 | 53.30 | |
Diabetic nephropathy | 2 | 2.70 | 31 | 7.31 | |
Hypertensive nephropathy | 12 | 16.22 | 70 | 16.51 | |
Chronic interstitial nephritis | 8 | 10.81 | 36 | 8.49 | |
Polycystic kidney | 1 | 1.35 | 26 | 6.13 | |
Other | 10 | 13.51 | 42 | 9.91 | |
Co-morbid condition | |||||
Hypertension | 54 | 72.91 | 360 | 84.91 | 0.011a |
P<0.05. P values were obtained from comparisons between the SHPT and control group. SHPT, secondary hyperparathyroidism; SD, standard deviation.